From: Abdominal DIBH reduces the cardiac dose even further: a prospective analysis
 | IMRT plans | P value | ||||
---|---|---|---|---|---|---|
Parameters | FB_IMRT | T-DIBH_IMRT | A-DIBH_IMRT | FB vs. T | FB vs. A | T vs. A |
PTV | ||||||
 Mean (Gy) | 49.43±0.33 | 49.37±0.47 | 49.33±0.49 | N.S. | N.S. | N.S. |
 D2% (Gy) | 51.46±0.61 | 51.29±0.61 | 51.16±0.57 | N.S. | N.S. | N.S. |
 V105% (%) | 0.37±0.56 | 0.36±0.97 | 0.14±0.43 | N.S. | N.S. | N.S. |
 HI (%) | 10.26±1.69 | 9.83±1.53 | 9.32±1.34 | N.S. | N.S. | N.S. |
Heart | ||||||
 Mean (Gy) | 1.96±2.25 | 1.37±0.44 | 1.18±0.26 | *** | *** | *** |
 D2% (Gy) | 14.67±5.29 | 7.62±5.29 | 5.61±3.03 | *** | *** | *** |
 V5 (%) | 6.58±3.25 | 2.83±2.54 | 1.80±1.46 | *** | *** | *** |
 V10 (%) | 4.01±2.32 | 1.32±1.60 | 0.68±0.84 | *** | *** | *** |
 V20 (%) | 0.59±0.49 | 0.16±0.29 | 0.05±0.11 | *** | *** | *** |
 V30 (%) | 0.07±0.09 | 0.01±0.04 | 0.00±0.00 | ** | ** | N.S. |
LADCA | ||||||
 Mean (Gy) | 16.10±7.45 | 8.60±6.60 | 7.35±5.42 | *** | *** | ** |
 D2% (Gy) | 25.07±11.02 | 14.24±9.43 | 13.11±9.51 | *** | *** | * |
 V5 (%) | 83.67±28.38 | 49.75±39.71 | 43.99±38.93 | *** | *** | ** |
 V10 (%) | 68.36±35.95 | 30.44±38.59 | 25.66±32.84 | *** | *** | * |
 V20 (%) | 36.27±31.19 | 10.77±23.47 | 5.69±14.18 | *** | *** | * |
 V30 (%) | 6.66±15.42 | 0.76±2.89 | 1.00±4.07 | ** | ** | N.S. |
Left lung | ||||||
 Mean (Gy) | 5.90±2.24 | 5.65±1.58 | 5.62±1.05 | N.S. | N.S. | N.S. |
 D2% (Gy) | 37.46±5.31 | 39.12±2.67 | 38.34±2.93 | N.S. | N.S. | N.S. |
 V5 (%) | 22.84±7.01 | 23.53±4.48 | 22.82±3.79 | N.S. | N.S. | N.S. |
 V10 (%) | 15.95±6.21 | 15.40±3.67 | 14.49±3.21 | N.S. | N.S. | * |
 V20 (%) | 11.12±5.55 | 10.67±3.39 | 9.83±3.01 | N.S. | N.S. | * |
 V30 (%) | 6.52±4.59 | 6.6±2.90 | 5.97±2.60 | N.S. | N.S. | N.S. |